AstraZeneca Says Amneal Infringed Diabetes Drug Patents
AstraZeneca Pharmaceuticals LP slapped Amneal Pharmaceuticals LLCÂ with a patent infringement suit in Delaware federal court Thursday, claiming the generic-drug maker's plans to make a version of AstraZeneca's diabetes drug come before...To view the full article, register now.
Already a subscriber? Click here to view full article